Patents by Inventor Manjunath S. Shet

Manjunath S. Shet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165103
    Abstract: Disclosed in certain embodiments is a pharmaceutical formulation (e.g., parenteral formulation) comprising a therapeutically effective amount of nalmefene or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable adjuvant (e.g., parenterally acceptable adjuvant) that promotes the rate at which the nalmefene or salt thereof is more rapidly absorbed into the systemic circulation of a subject identified as in need thereof.
    Type: Application
    Filed: November 14, 2023
    Publication date: May 23, 2024
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet
  • Patent number: 11865112
    Abstract: Disclosed in certain embodiments is a pharmaceutical formulation (e.g., parenteral formulation) comprising a therapeutically effective amount of nalmefene or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable adjuvant (e.g., parenterally acceptable adjuvant) that promotes the rate at which the nalmefene or salt thereof is more rapidly absorbed into the systemic circulation of a subject identified as in need thereof.
    Type: Grant
    Filed: November 5, 2019
    Date of Patent: January 9, 2024
    Assignee: Purdue Pharma L.P.
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet
  • Patent number: 11857547
    Abstract: Disclosed in certain embodiments is a pharmaceutical formulation (e.g., parenteral formulation) comprising a therapeutically effective amount of nalmefene or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable adjuvant (e.g., parenterally acceptable adjuvant) that promotes the rate at which the nalmefene or salt thereof is more rapidly absorbed into the systemic circulation of a subject identified as in need thereof.
    Type: Grant
    Filed: May 9, 2023
    Date of Patent: January 2, 2024
    Assignee: Purdue Pharma L.P.
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet
  • Publication number: 20230270741
    Abstract: Disclosed in certain embodiments is a pharmaceutical formulation (e.g., parenteral formulation) comprising a therapeutically effective amount of nalmefene or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable adjuvant (e.g., parenterally acceptable adjuvant) that promotes the rate at which the nalmefene or salt thereof is more rapidly absorbed into the systemic circulation of a subject identified as in need thereof.
    Type: Application
    Filed: May 9, 2023
    Publication date: August 31, 2023
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet
  • Publication number: 20230181508
    Abstract: Disclosed in certain embodiments is a method of treating Parkinson's disease comprising administering to the olfactory region of the nose of a patient in need thereof a pharmaceutical composition comprising levodopa or a pharmaceutically acceptable salt thereof and a positively charged amino acid.
    Type: Application
    Filed: August 30, 2021
    Publication date: June 15, 2023
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet
  • Publication number: 20230143454
    Abstract: Disclosed in certain embodiments is a parenteral formulation comprising a therapeutically effective amount of an emergency rescue active pharmaceutical ingredient and a parenterally acceptable adjuvant in an amount that enhances the absorption of the emergency rescue active pharmaceutical ingredient (ER-API) into the systemic circulation. The enhanced absorption may be evidence by a faster onset time, a faster Tmax and/or a greater Cmax and/or a greater AUClast and/or a greater AUC0.25 and/or a greater AUC0.5 and/or a greater AUC0.75 and/or a greater AUC1 and/or increased bioavailability as compared to formulations without the adjuvant.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 11, 2023
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet
  • Publication number: 20230095235
    Abstract: Disclosed in certain embodiments is a formulation comprising a therapeutically effective amount of naloxone or a pharmaceutically acceptable salt thereof and an adjuvant that enhances the absorption of the naloxone into the systemic circulation of a subject. Also disclosed herein are a method of treatment and a kit that may be utilized in treatment.
    Type: Application
    Filed: February 26, 2021
    Publication date: March 30, 2023
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet
  • Publication number: 20200138805
    Abstract: Disclosed in certain embodiments is a pharmaceutical formulation (e.g., parenteral formulation) comprising a therapeutically effective amount of nalmefene or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable adjuvant (e.g., parenterally acceptable adjuvant) that promotes the rate at which the nalmefene or salt thereof is more rapidly absorbed into the systemic circulation of a subject identified as in need thereof.
    Type: Application
    Filed: November 5, 2019
    Publication date: May 7, 2020
    Inventors: Haiyong Hugh Huang, Manjunath S. Shet